Free Trial
→ Has Trump finally met his match? (From Behind the Markets) (Ad) Free DNTH Stock Alerts

Dianthus Therapeutics (DNTH) SEC Filings & 10K Form

Dianthus Therapeutics logo
$23.67 -0.03 (-0.13%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$23.65 -0.02 (-0.08%)
As of 02/21/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Dianthus Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
5:32 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
6:54 AM		BCLS Fund III Investments, LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
4:42 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Octagon Capital Advisors LP (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:21 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:23 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:27 PM		CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
8:19 PM		Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13D/A
11/22/2024
3:41 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
11/14/2024
4:47 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:48 PM		5AM Partners VII, LLC (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G/A
10/24/2024
1:02 PM		BlackRock, Inc. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G
10/21/2024
3:19 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form RW
10/09/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
10/09/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
10/01/2024
7:00 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:31 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/01/2024
3:36 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/18/2024
4:38 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
4:32 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
7:45 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Viridian, LLC (Filed by)
Form SC 13D/A
08/08/2024
3:26 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2024
7:00 AM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
6:57 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Lawton Alison Frances (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
McGeorge Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:59 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:02 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:03 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Garcia Marino (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:04 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Savitz Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:04 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:05 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:05 PM		CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:24 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 424B3
05/28/2024
4:20 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:20 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:08 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:05 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form DEF 14A
04/11/2024
3:09 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form DEFA14A
04/11/2024
3:10 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form ARS
04/01/2024
5:34 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13D/A
Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.
04/01/2024
5:21 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
03/21/2024
4:02 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-1/A
03/21/2024
4:10 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:DNTH) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
What is this southern state hiding?
The financial press had a field day this week after President Donald Trump and Department of Government Effici...
Stansberry Research | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
How to trade Executive Order 14154
Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...
Porter & Company | Sponsored
Major AI announcement for 2025
BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI Stocks
Brownstone Research | Sponsored